Orthofix Medical Inc.

Case Form

Find Out if You Potentially Qualify for a Financial Reward by filling out the form.

The submission of this form does not create an attorney-client relationship.

Investigation Details

On September 12, 2023, Orthofix announced the “the unanimous decision by the Board’s independent directors to terminate for cause” Orthofix’s Chief Executive Officer, Chief Financial Officer, and Chief Legal Officer due to alleged violations of the Company’s Code of Conduct. Following this news, Orthofix’s stock price fell by $5.62 per share, or approximately 30%, to close at $13.01 per share.